Sensitivity analysis of a mathematical model of Alzheimer's disease progression unveils important causal pathways

QR Code

Sensitivity analysis of a mathematical model of Alzheimer's disease progression unveils important causal pathways

IntroductionMathematical models serve as essential tools to investigate brain aging, the onset of Alzheimer's disease (AD) and its progression. By studying the representation of the complex dynamics of brain aging processes, such as amyloid beta (Aβ) deposition, tau tangles, neuro-inflammation,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Seyedadel Moravveji, Halima Sadia, Nicolas Doyon, Simon Duchesne
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Neuroinformatics
Subjects:	Alzheimer's disease mathematical models neural density sensitivity analysis amyloid beta tau proteins
Online Access:	https://www.frontiersin.org/articles/10.3389/fninf.2025.1590968/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Associations of Plasma and CSF Osteocalcin Levels With CSF ATN Biomarkers and Cognitive Functions in Alzheimer's Disease
by: Xian‐Le Bu, et al.
Published: (2025-07-01)

Autophagy and Alzheimer’s Disease: Mechanisms and Impact Beyond the Brain
by: Zaw Myo Hein, et al.
Published: (2025-06-01)

Rest‐activity rhythm characteristics associated with lower cognitive performance and Alzheimer's disease biomarkers in midlife women
by: Alexandra Paget‐Blanc, et al.
Published: (2025-04-01)

New Possibilities for Evaluating Markers of Alzheimer's Disease in Blood Serum
by: S. V. Vorobev, et al.
Published: (2025-06-01)

Interplay Between Aging and Tau Pathology in Alzheimer’s Disease: Mechanisms and Translational Perspectives
by: Mohammed Alrouji, et al.
Published: (2025-06-01)

The origin of Alzheimer’s disease: Prions?
by: Dongchuan Yang, et al.
Published: (2025-05-01)

Neurofilament, but not Alzheimer disease biomarkers in the acute phase correlate with cognitive performance after cardiac arrest
by: Johannes Lorentzson, et al.
Published: (2025-09-01)

Alzheimer’s Disease in the Context of an Aging Society: Challenges and Future Directions
by: Aleksandra Boral, et al.
Published: (2025-07-01)

Beneficial Influence of Agomelatine Treatment on Behavioral Impairments in AΒ-Induced Rat Model of Alzheimer’s Disease
by: Kalina Ilieva, et al.
Published: (2020-12-01)

Alzheimer’s Disease: The Impact of Gut Microbiota and Sex Differences on Pathogenesis and Treatment Strategies
by: Kh. A. Abdel-Sater
Published: (2025-05-01)

Analytical and clinical validation of a high accuracy fully automated digital immunoassay for plasma phospho-Tau 217 for clinical use in detecting amyloid pathology
by: David Wilson, et al.
Published: (2025-07-01)

Rising of intracellular NAD+ level and oppositely directed changes in CD38 expression in hippocampal cells in experimental Alzheimer’s disease
by: A. A. Semenova, et al.
Published: (2021-10-01)

Role of berberine in Alzheimer&rsquo;s disease
by: Cai Z, et al.
Published: (2016-10-01)

Neuronal and Glial α7 Nicotinic Acetylcholine Receptors: Role in Alzheimer’s Disease Pathophysiology
by: Kerry Rennie
Published: (2025-06-01)

Catalpol alleviates amyloid- generation and neuronal oxidative stress injury via activating the Keap1-Nrf2/ARE signaling pathway in the immortalized lymphocytes from patients with late-onset Alzheimer’s disease and SKNMC cells co-culture model
by: Caixia Xiang, et al.
Published: (2024-12-01)

APOE GENE POLYMORPHISM: THE IMPACT OF APOE4 ALLELE ON SYSTEMIC INFLAMMATION AND ITS ROLE IN THE PATHOGENESIS OF ALZHEIMER’S DISEASE
by: I. K. Malashenkova, et al.
Published: (2018-06-01)

Relationship between tau-PET and quantitative susceptibility mapping in atypical Alzheimer’s disease
by: Neha Singh-Reilly, et al.
Published: (2025-07-01)

Why testing and diagnosis for Alzheimer's disease are mission critical
by: Brent W. Beasley
Published: (2025-04-01)

Toxicity of glyphosate accelerates neurodegeneration in Caenorhabditis elegans model of Alzheimer’s disease
by: Nisha Rani, et al.
Published: (2025-07-01)

The effect of oral administration of NXP032 equivalent to intraperitoneal administration in an Alzheimer’s disease model
by: Jae Min Lee, et al.
Published: (2025-07-01)

Study of the possibility of correcting behavioral disorders in rats with a stereotaxic model of Alzheimer's disease
by: I. I. Semina, et al.
Published: (2023-05-01)

Understanding the impact of amyloid beta targeted therapies on biomarkers and clinical endpoints in Alzheimer's disease
by: Ronald C. Petersen, et al.
Published: (2025-04-01)

The Role of APOA-I in Alzheimer’s Disease: Bridging Peripheral Tissues and the Central Nervous System
by: Guanfeng Xie, et al.
Published: (2025-05-01)

Effect of Tau Fragment and Membrane Interactions on Membrane Permeabilization and Peptide Aggregation
by: Majedul Islam, et al.
Published: (2025-07-01)

Optical Taxonomic Signal and the Diagnosis of Alzheimer's Disease
by: Frank A. Greco, et al.
Published: (2025-01-01)

Role of the chaperonin TCP-1 ring complex in protein aggregation and neurodegeneration
by: Vanlalrinchhani Varte, et al.
Published: (2025-07-01)

Association between educational attainment and amyloid deposition across the spectrum from normal cognition to dementia: A meta-analysis
by: Fatemeh Sedghi, et al.
Published: (2025-12-01)

System readiness and the patient care pathway for Alzheimer's disease diagnosis and treatment
by: B. Joy Snider, et al.
Published: (2025-04-01)

The Role and Pathogenesis of Tau Protein in Alzheimer’s Disease
by: Xiaoyue Hong, et al.
Published: (2025-06-01)

Brain‐derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementia
by: Cassandra Marotta, et al.
Published: (2025-04-01)

Isoforms of Phosphorylated Tau as Potential Biomarkers for Alzheimer’s Disease: The Contribution of Mass Spectrometry-Based Proteomics
by: Marco Agostini, et al.
Published: (2025-06-01)

Detection of hyperphosphorylated tau protein and &alpha;-synuclein in spinal cord of patients with Alzheimer&rsquo;s disease
by: Guo Y, et al.
Published: (2016-02-01)

Cytoskeletal Proteins and Alzheimer’s Disease Pathogenesis: Focusing on the Interplay with Tau Pathology
by: Gege Jiang, et al.
Published: (2025-06-01)

Advanced Biosensing Technologies: Leading Innovations in Alzheimer’s Disease Diagnosis
by: Stephen Rathinaraj Benjamin, et al.
Published: (2025-06-01)

Amyloid β 1-42 Can Form Ion Channels as Small as Gramicidin in Model Lipid Membranes
by: Yue Xu, et al.
Published: (2025-07-01)

Human iPSC-derived cerebral organoids reveal oxytocin-mediated protection against amyloid-β pathology
by: Tomoki Asaba, et al.
Published: (2025-12-01)

Mannose Promotes β‐Amyloid Pathology by Regulating BACE1 Glycosylation in Alzheimer's Disease
by: Chensi Liang, et al.
Published: (2025-03-01)

Alzheimer's disease drug development pipeline: 2025
by: Jeffrey L. Cummings, et al.
Published: (2025-04-01)

Generating real‐world evidence in early Alzheimer's disease: Considerations for applying the target trial emulation framework to study the safety of anti‐amyloid therapies
by: Xiaojuan Li, et al.
Published: (2025-04-01)

AhR regulation of amyloid beta-induced inflammation in astrocyte cells
by: Emmanuel Ojo, et al.
Published: (2025-07-01)